Omicron Vaccine

Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.

Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.

The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.

Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.

Just when the world was starting to believe that the novel coronavirus pandemic, the deadly new Omicron BF.7 strain reinforced the home truth that the world has certainly not seen the last of the pandemic.

2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.

The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.

The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.

Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that's now the world's most widespread.

The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.

The UK's drug regulator said Monday it has approved an updated Moderna vaccine against the coronavirus that targets the Omicron variant as well as the original form.

The strains of Omicron circulating in Delhi is more infectious than the base strain that surfaced in January this year and along with it, the effectiveness of the vaccines currently available has dropped 20 to 30 per cent,

A panel of US medical experts on Tuesday called for Omicron-specific boosters this fall, as anticipation mounts that Covid vaccines will be needed on an ongoing seasonal basis, as is the case for influenza.

India recorded 13,313 new COVID-19 cases in the last 24 hours, taking the total number of cases to 4,33,44,958. According to Union health ministry data, the number of active cases increased to 83,990 in the country.

Scientists at the institute have developed a new nanovaccine that shows promise in providing universal protection against all major Covid-19 variants.

Pune-based Gennova Biopharmaceuticals Ltd on Tuesday said its mRNA COVID-19 booster vaccine against the Omicron variant, GEMCOVAC-OM, has received emergency use authorisation from the Drugs Controller General of India.

The new Covid-19 variant, XBB.1.16 is responsible for the surge in cases in India. According to the Health Ministry data, India has reported a total of 5,880 covid cases in the last 24 hours.

Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works well against the Omicron variant of coronavirus.

Fifty to 70 per cent "children" below 19 years globally were susceptible to the SARS-CoV-2 infection by the end of 2021 and before the Omicron wave, showing a need for more effective vaccines and better vaccination coverage, according to a study.

Just when the world was starting to believe that the novel coronavirus pandemic, the deadly new Omicron BF.7 strain reinforced the home truth that the world has certainly not seen the last of the pandemic.

2022 saw a new wave of infections driven by the Omicron variant of coronavirus which ultimately subsided, putting India along with the world on the route to normalcy before fresh concerns arose amid rise in cases globally at the fag end of the year.

The UK health authorities on Saturday approved a second "bivalent" vaccine to be used as a booster vaccine to target both the Omicron and original strain of COVID-19.

The Serum Institute of India will try to launch Omicron-specific vaccine for COVID-19 after six months, its CEO Adar Poonawalla said on Thursday.

Moderna Inc. has just received approval from the UK for a Covid-19 booster shot that targets omicron, the version of the virus that's now the world's most widespread.

The Serum Institute of India is working on an Omicron specific vaccine with Novavax, institute chief Adar Poonawalla told NDTV in an exclusive interview today. The vaccine can be expected by the year-end, he said.

The UK's drug regulator said Monday it has approved an updated Moderna vaccine against the coronavirus that targets the Omicron variant as well as the original form.

The strains of Omicron circulating in Delhi is more infectious than the base strain that surfaced in January this year and along with it, the effectiveness of the vaccines currently available has dropped 20 to 30 per cent,

A panel of US medical experts on Tuesday called for Omicron-specific boosters this fall, as anticipation mounts that Covid vaccines will be needed on an ongoing seasonal basis, as is the case for influenza.

India recorded 13,313 new COVID-19 cases in the last 24 hours, taking the total number of cases to 4,33,44,958. According to Union health ministry data, the number of active cases increased to 83,990 in the country.